Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy
Objectives: The recurrence rate of benign endometrial polyps after a hysteroscopic polypectomy is low, between 0% and 15%. There are limited follow-up duration data on recurrence factors for benign polyps after hysteroscopic polypectomy, including recurrences with Versapoint® versus resectoscope. Th...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Gynecology and Minimally Invasive Therapy |
Subjects: | |
Online Access: | http://www.e-gmit.com/article.asp?issn=2213-3070;year=2020;volume=9;issue=4;spage=209;epage=214;aulast=Cea |
_version_ | 1819017572819927040 |
---|---|
author | Jorge Cea Garcia Antonio Jiménez Caraballo MarÍa del Mar Rios Vallejo Ignacio Zapardiel |
author_facet | Jorge Cea Garcia Antonio Jiménez Caraballo MarÍa del Mar Rios Vallejo Ignacio Zapardiel |
author_sort | Jorge Cea Garcia |
collection | DOAJ |
description | Objectives: The recurrence rate of benign endometrial polyps after a hysteroscopic polypectomy is low, between 0% and 15%. There are limited follow-up duration data on recurrence factors for benign polyps after hysteroscopic polypectomy, including recurrences with Versapoint® versus resectoscope. This study aims to estimate the rate of symptomatic recurrence following hysteroscopic polypectomy and to analyze the possible risk factors involved with Versapoint® versus resectoscope.
Materials and Methods: We designed a retrospective cohort study in a tertiary university hospital in Seville (Spain) which looked at the results of polypectomy with a 9-mm resectoscope on 42 women between 2008 and 2015 compared to 151 women using Versapoint® during 2014.
Results: The rate of first recurrence was 24.35%. There was a strong positive correlation between the recurrence and the follow-up duration (odds ratio [OR] = 2.58; 95% confidence interval [CI] = 1.68–5.04; P = 0.000), the polyps causing abnormal uterine bleeding (OR = 2.5; 95% CI: 1.1–3; P = 0.04), and a polyp size >15 mm (OR = 1.63; 95% CI = 1.3–3.1; P = 0.02). There were no statistical differences in polyps' recurrence among the types of hysteroscopic polypectomy (P > 0.05).
Conclusion: The main risk factors for recurrence were polyps causing abnormal uterine bleeding, size, and follow-up duration. |
first_indexed | 2024-12-21T03:05:40Z |
format | Article |
id | doaj.art-1d04562a87e44d139369953e2b708942 |
institution | Directory Open Access Journal |
issn | 2213-3070 |
language | English |
last_indexed | 2024-12-21T03:05:40Z |
publishDate | 2020-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Gynecology and Minimally Invasive Therapy |
spelling | doaj.art-1d04562a87e44d139369953e2b7089422022-12-21T19:18:05ZengWolters Kluwer Medknow PublicationsGynecology and Minimally Invasive Therapy2213-30702020-01-019420921410.4103/GMIT.GMIT_102_19Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomyJorge Cea GarciaAntonio Jiménez CaraballoMarÍa del Mar Rios VallejoIgnacio ZapardielObjectives: The recurrence rate of benign endometrial polyps after a hysteroscopic polypectomy is low, between 0% and 15%. There are limited follow-up duration data on recurrence factors for benign polyps after hysteroscopic polypectomy, including recurrences with Versapoint® versus resectoscope. This study aims to estimate the rate of symptomatic recurrence following hysteroscopic polypectomy and to analyze the possible risk factors involved with Versapoint® versus resectoscope. Materials and Methods: We designed a retrospective cohort study in a tertiary university hospital in Seville (Spain) which looked at the results of polypectomy with a 9-mm resectoscope on 42 women between 2008 and 2015 compared to 151 women using Versapoint® during 2014. Results: The rate of first recurrence was 24.35%. There was a strong positive correlation between the recurrence and the follow-up duration (odds ratio [OR] = 2.58; 95% confidence interval [CI] = 1.68–5.04; P = 0.000), the polyps causing abnormal uterine bleeding (OR = 2.5; 95% CI: 1.1–3; P = 0.04), and a polyp size >15 mm (OR = 1.63; 95% CI = 1.3–3.1; P = 0.02). There were no statistical differences in polyps' recurrence among the types of hysteroscopic polypectomy (P > 0.05). Conclusion: The main risk factors for recurrence were polyps causing abnormal uterine bleeding, size, and follow-up duration.http://www.e-gmit.com/article.asp?issn=2213-3070;year=2020;volume=9;issue=4;spage=209;epage=214;aulast=Ceaendometriumhysteroscopypolyprecurrencerisk factors |
spellingShingle | Jorge Cea Garcia Antonio Jiménez Caraballo MarÍa del Mar Rios Vallejo Ignacio Zapardiel Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy Gynecology and Minimally Invasive Therapy endometrium hysteroscopy polyp recurrence risk factors |
title | Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy |
title_full | Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy |
title_fullStr | Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy |
title_full_unstemmed | Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy |
title_short | Retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy |
title_sort | retrospective cohort study on the symptomatic recurrence pattern after hysteroscopic polypectomy |
topic | endometrium hysteroscopy polyp recurrence risk factors |
url | http://www.e-gmit.com/article.asp?issn=2213-3070;year=2020;volume=9;issue=4;spage=209;epage=214;aulast=Cea |
work_keys_str_mv | AT jorgeceagarcia retrospectivecohortstudyonthesymptomaticrecurrencepatternafterhysteroscopicpolypectomy AT antoniojimenezcaraballo retrospectivecohortstudyonthesymptomaticrecurrencepatternafterhysteroscopicpolypectomy AT mariadelmarriosvallejo retrospectivecohortstudyonthesymptomaticrecurrencepatternafterhysteroscopicpolypectomy AT ignaciozapardiel retrospectivecohortstudyonthesymptomaticrecurrencepatternafterhysteroscopicpolypectomy |